Command Palette

Search for a command to run...

Clinical Trials · NCT07041983

24-h Energy Expenditure and Anti-obesity Medication

Enrolling By InvitationN/ATirzepatide (Investigational)
Phase
N/A
Recruitment status
Enrolling By Invitation
Sponsor
University of Pisa
Enrollment
30
Start date
Jul 2025
Locations
1 site, Italy
Primary endpoint
change in 24h energy expenditure after 6 months of treatment
View Tirzepatide compound reference